Soumit Roy
Stock Analyst at Jones Trading
(1.36)
# 3,286
Out of 4,826 analysts
37
Total ratings
13.79%
Success rate
-8.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MURA Mural Oncology | Downgrades: Hold | n/a | $2.53 | - | 2 | Mar 25, 2025 | |
| CRVO CervoMed | Upgrades: Buy | $15 | $9.94 | +50.91% | 3 | Mar 13, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $2.39 | +318.41% | 1 | Mar 12, 2025 | |
| BEAM Beam Therapeutics | Upgrades: Buy | $34 | $19.82 | +71.54% | 2 | Mar 10, 2025 | |
| INAB IN8bio | Upgrades: Buy | $1.2 | $0.17 | +626.39% | 4 | Feb 11, 2025 | |
| OKUR OnKure Therapeutics | Initiates: Buy | $32 | $2.46 | +1,200.81% | 1 | Jan 28, 2025 | |
| EPIX ESSA Pharma | Downgrades: Hold | n/a | $1.71 | - | 1 | Nov 1, 2024 | |
| ELTX Elicio Therapeutics | Initiates: Buy | $9 | $5.44 | +65.44% | 1 | Oct 31, 2024 | |
| ELVN Enliven Therapeutics | Initiates: Buy | $36 | $20.33 | +77.08% | 1 | Oct 31, 2024 | |
| ORIC ORIC Pharmaceuticals | Initiates: Buy | $17 | $5.71 | +197.72% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $1.54 | +744.16% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $4 | $0.68 | +491.72% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.60 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.36 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $8.31 | +213.06% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $29.79 | +134.98% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $45.25 | -77.90% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $1.41 | +1,743.97% | 1 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.55 | +1,551.38% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.78 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $8.10 | +887.65% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.09 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $6.70 | +4,676.12% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $5.67 | +14,185.71% | 1 | Feb 24, 2021 |
Mural Oncology
Mar 25, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.53
Upside: -
CervoMed
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $9.94
Upside: +50.91%
Nuvation Bio
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $2.39
Upside: +318.41%
Beam Therapeutics
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $19.82
Upside: +71.54%
IN8bio
Feb 11, 2025
Upgrades: Buy
Price Target: $1.2
Current: $0.17
Upside: +626.39%
OnKure Therapeutics
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $2.46
Upside: +1,200.81%
ESSA Pharma
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.71
Upside: -
Elicio Therapeutics
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $5.44
Upside: +65.44%
Enliven Therapeutics
Oct 31, 2024
Initiates: Buy
Price Target: $36
Current: $20.33
Upside: +77.08%
ORIC Pharmaceuticals
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $5.71
Upside: +197.72%
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $1.54
Upside: +744.16%
Sep 11, 2024
Maintains: Buy
Price Target: $6 → $4
Current: $0.68
Upside: +491.72%
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.60
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.36
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $8.31
Upside: +213.06%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $29.79
Upside: +134.98%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $45.25
Upside: -77.90%
Aug 18, 2023
Initiates: Buy
Price Target: $26
Current: $1.41
Upside: +1,743.97%
May 24, 2023
Initiates: Buy
Price Target: $9
Current: $0.55
Upside: +1,551.38%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.78
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $8.10
Upside: +887.65%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.09
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $320
Current: $6.70
Upside: +4,676.12%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $5.67
Upside: +14,185.71%